Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Nachury

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Annales De Dermatologie Et De Venereologie|October 11, 2007
[Cronkhite-Canada syndrome]T Duong, F Marrache, M Nachury, et al.
Techniques in Coloproctology|August 22, 2013
Efficacy of sacral nerve stimulation for poor functional results of J-pouch ileoanal anastomosisA Lebas, M Rogosnitzky, C Chater, et al.
Alimentary Pharmacology & Therapeutics|December 1, 2023
Long-term effectiveness and acceptability of switching from intravenous to subcutaneous infliximab in patients with inflammatory bowel disease treated with intensified doses: The REMSWITCH-LT studyA Buisson, M Nachury, M Bazoge, et al.
Journal of Crohn'S & Colitis|July 14, 2016
Endoscopic Detection of Small Bowel Dysplasia and Adenocarcinoma in Crohn's Disease: A Prospective Cohort-Study in High-Risk PatientsM Simon, J Cosnes, J M Gornet, et al.
Digestive Diseases and Sciences|July 13, 2016
Ileal or Anastomotic Location of Lesions Does Not Impact Rate of Postoperative Recurrence in Crohn's Disease Patients Classified i2 on the Rutgeerts ScoreP Bayart, N Duveau, M Nachury, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 28, 2024
Infliximab is an effective option in patients with ulcerative colitis previously exposed to full subcutaneous anti-TNF agent: Results from a real-world multicenter studyM Hupé, A Streichenberger, P Wils, et al.
Journal of Crohn'S & Colitis|May 5, 2022
Comparative Risk of Incident Cancer in Patients with Inflammatory Bowel Disease with Prior Non-digestive Malignancy According to Immunomodulator: a Multicentre Cohort StudyF Poullenot, A Amiot, M Nachury, et al.
Journal of Crohn'S & Colitis|January 20, 2016
Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel DiseaseL Marthey, C Mateus, C Mussini, et al.
Journal of Crohn'S & Colitis|September 10, 2015
Fistula Plug in Fistulising Ano-Perineal Crohn's Disease: a Randomised Controlled TrialA Senéjoux, L Siproudhis, L Abramowitz, et al.
Journal of Crohn'S & Colitis|February 23, 2019
Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multicentre, prospective, observational cohort studyG Pineton de Chambrun, B Pariente, P Seksik, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Annales De Dermatologie Et De Venereologie|October 11, 2007
[Cronkhite-Canada syndrome]T Duong, F Marrache, M Nachury, et al.
Techniques in Coloproctology|August 22, 2013
Efficacy of sacral nerve stimulation for poor functional results of J-pouch ileoanal anastomosisA Lebas, M Rogosnitzky, C Chater, et al.
Alimentary Pharmacology & Therapeutics|December 1, 2023
Long-term effectiveness and acceptability of switching from intravenous to subcutaneous infliximab in patients with inflammatory bowel disease treated with intensified doses: The REMSWITCH-LT studyA Buisson, M Nachury, M Bazoge, et al.
Journal of Crohn'S & Colitis|July 14, 2016
Endoscopic Detection of Small Bowel Dysplasia and Adenocarcinoma in Crohn's Disease: A Prospective Cohort-Study in High-Risk PatientsM Simon, J Cosnes, J M Gornet, et al.
Digestive Diseases and Sciences|July 13, 2016
Ileal or Anastomotic Location of Lesions Does Not Impact Rate of Postoperative Recurrence in Crohn's Disease Patients Classified i2 on the Rutgeerts ScoreP Bayart, N Duveau, M Nachury, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 28, 2024
Infliximab is an effective option in patients with ulcerative colitis previously exposed to full subcutaneous anti-TNF agent: Results from a real-world multicenter studyM Hupé, A Streichenberger, P Wils, et al.
Journal of Crohn'S & Colitis|May 5, 2022
Comparative Risk of Incident Cancer in Patients with Inflammatory Bowel Disease with Prior Non-digestive Malignancy According to Immunomodulator: a Multicentre Cohort StudyF Poullenot, A Amiot, M Nachury, et al.
Journal of Crohn'S & Colitis|January 20, 2016
Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel DiseaseL Marthey, C Mateus, C Mussini, et al.
Journal of Crohn'S & Colitis|September 10, 2015
Fistula Plug in Fistulising Ano-Perineal Crohn's Disease: a Randomised Controlled TrialA Senéjoux, L Siproudhis, L Abramowitz, et al.
Journal of Crohn'S & Colitis|February 23, 2019
Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multicentre, prospective, observational cohort studyG Pineton de Chambrun, B Pariente, P Seksik, et al.
Pageof 2